Opdivo demonstrated significant overall survival benefit over chemotherapy alone in both PD-L1 positive and all-randomized populations in both treatment armsCheckMate -648 marks the third global trial in which Opdivo demonstrated a significant benefit for patients with upper gastrointestinal cancersData to be featur.
Lung cancer is one of the most prevalent cancers and a leading cause of cancer-related deaths worldwide. People who smoke cigarettes are 15 to 30 times more likely to get lung cancer or die from lung cancer than people who do not smoke.
World No Tobacco Day is observed on May 31. People who smoke cigarettes are 15 to 30 times more likely to get lung cancer or die from lung cancer, reveals report.